Premium
HIV topic update: protease inhibitor therapy and oral health care
Author(s) -
Porter SR,
Scully C
Publication year - 1998
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/j.1601-0825.1998.tb00273.x
Subject(s) - medicine , protease inhibitor (pharmacology) , adverse effect , intensive care medicine , human immunodeficiency virus (hiv) , oral health , taste disorder , disease , taste , antiretroviral therapy , viral load , immunology , family medicine , psychology , neuroscience
Protease inhibitors have been a major advance in the management of HIV disease and have reduced the frequency and severity of many complications, including some oral lesions. They may also be of value in the management of occupational exposures to the virus. However, they may produce adverse effects including oral symptoms such as paraesthesia, taste disturbances and xerostomia, and may interact with a number of drugs used in oral health care. This article summarises the current situation.